ENTRY       D09017                      Drug
NAME        Ticagrelor (JAN/USAN/INN);
            Brilinta (TN)
PRODUCT     BRILINTA (AstraZeneca Pharmaceuticals LP)
            BRILINTA (Cardinal Health 107)
  GENERIC   TICAGRELOR (Amneal Pharmaceuticals NY LLC)
FORMULA     C23H28F2N6O4S
EXACT_MASS  522.1861
MOL_WEIGHT  522.568
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
             DG01809  P2Y12 receptor antagonist
            Metabolizing enzyme substrate
             DG01633  CYP3A/CYP3A4 substrate
            Metabolizing enzyme inhibitor
             DG02852  CYP3A/CYP3A4 inhibitor
            Transporter substrate
             DG01665  ABCB1 substrate
            Transporter inhibitor
             DG01622  ABCB1 inhibitor
REMARK      Therapeutic category: 3399
            ATC code: B01AC24
            Product: D09017<JP/US>
EFFICACY    Platelet aggregation inhibitor, Purinergic receptor P2Y12 antagonist
  DISEASE   Myocardial infarction [DS:H01730]
COMMENT     Prevention of thromboembolic events in patients with acute coronary syndrome
TARGET      P2RY12 [HSA:64805] [KO:K04298]
  PATHWAY   hsa04611(64805)  Platelet activation
METABOLISM  Enzyme: CYP3A [HSA:1576 1577 1551]
            Transporter: ABCB1 [HSA:5243]
INTERACTION CYP inhibition: CYP3A [HSA:1576 1577 1551]
            Transporter inhibition: ABCB1 [HSA:5243]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC24 Ticagrelor
                  D09017  Ticagrelor (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Blood Products and Modifiers
              Platelet Modifying Agents
               Adenosine Diphosphate P2Y12 Inhibitors
                Ticagrelor
                 D09017  Ticagrelor (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              33  Blood and body fluid agents
               339  Miscellaneous
                3399  Others
                 D09017  Ticagrelor (JAN/USAN/INN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                D09017  Ticagrelor
              DG01809  P2Y12 receptor antagonist
               D09017  Ticagrelor
             Metabolizing enzyme substrate
              DG01633  CYP3A/CYP3A4 substrate
               D09017  Ticagrelor
             Metabolizing enzyme inhibitor
              DG02852  CYP3A/CYP3A4 inhibitor
               D09017  Ticagrelor
             Transporter substrate
              DG01665  ABCB1 substrate
               D09017  Ticagrelor
             Transporter inhibitor
              DG01622  ABCB1 inhibitor
               D09017  Ticagrelor
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Purine / pyrimidine
                P2RY12
                 D09017  Ticagrelor (JAN/USAN/INN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D09017
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09017
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D09017
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D09017
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09017
             Drug transporters
              D09017
            Pharmacogenomic biomarkers [br08341.html]
             Polymorphisms and mutations affecting drug response
              D09017
DBLINKS     CAS: 274693-27-5
            PubChem: 96025700
            ChEBI: 68558
            PDB-CCD: TIQ
            LigandBox: D09017
ATOM        36
            1   C8y C    16.5612  -16.1984
            2   N5x N    16.5612  -17.6066
            3   C8y C    17.7582  -18.3108
            4   C8y C    19.0256  -17.6066
            5   C8y C    19.0256  -16.1984
            6   N5x N    17.7582  -15.4943
            7   N5x N    20.3634  -18.0291
            8   N5x N    21.1379  -16.9025
            9   N4y N    20.3634  -15.7759
            10  S2a S    15.3642  -15.4943
            11  C1b C    14.1672  -16.1984
            12  C1b C    12.9702  -15.4943
            13  C1a C    11.7732  -16.1984
            14  N1b N    17.7582  -19.7190
            15  C1y C    16.5612  -20.4231
            16  C1y C    15.1529  -20.4231
            17  C1x C    15.8570  -21.6201
            18  C8y C    13.9559  -19.7190
            19  C8x C    13.9559  -18.3108
            20  C8x C    12.7589  -17.6066
            21  C8y C    11.5619  -18.3108
            22  C8y C    11.5619  -19.7190
            23  C8x C    12.7589  -20.4231
            24  X   F    10.3649  -17.6066
            25  X   F    10.3649  -20.4231
            26  C1y C    20.8563  -14.4381
            27  C1x C    22.1941  -14.0156
            28  C1y C    22.1941  -12.6074
            29  C1y C    20.8563  -12.1145
            30  C1y C    20.0113  -13.2411
            31  O1a O    18.6031  -13.2411
            32  O1a O    20.4338  -10.7767
            33  C1b C    25.7851  -11.9033
            34  O1a O    26.9821  -12.6074
            35  C1b C    24.5881  -12.6074
            36  O2a O    23.3911  -11.9033
BOND        40
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     4   7 1
            8     7   8 2
            9     8   9 1
            10    5   9 1
            11    1  10 1
            12   10  11 1
            13   11  12 1
            14   12  13 1
            15    3  14 1
            16   15  14 1 #Down
            17   16  15 1
            18   17  16 1
            19   15  17 1
            20   16  18 1 #Up
            21   18  19 2
            22   19  20 1
            23   20  21 2
            24   21  22 1
            25   22  23 2
            26   18  23 1
            27   21  24 1
            28   22  25 1
            29   26   9 1 #Up
            30   26  27 1
            31   27  28 1
            32   28  29 1
            33   29  30 1
            34   26  30 1
            35   30  31 1 #Down
            36   29  32 1 #Down
            37   33  34 1
            38   33  35 1
            39   35  36 1
            40   28  36 1 #Up
///
